|
|
|
Volumn 13, Issue 12, 2010, Pages 825-827
|
|
Alzheimer's disease drug discovery-11th international conference-Promising new therapeutic approaches
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
3ALPHA HYDROXY 5ALPHA PREGNAN 20 ONE;
4 AMINOBUTYRIC ACID A RECEPTOR;
AMYLOID BETA PROTEIN[1-42];
BMS 4;
CT 0093;
CT 0109;
ETIRACETAM;
KLOTHO PROTEIN;
LDN 33960;
PHOSPHODIESTERASE V INHIBITOR;
PROTEIN DERIVATIVE;
PROTEIN TYROSINE PHOSPHATASE;
PROTEIN TYROSINE PHOSPHATASE INHIBITOR;
SILDENAFIL;
UNCLASSIFIED DRUG;
YF 012403;
ALZHEIMER DISEASE;
COGNITION;
COGNITIVE DEFECT;
CONFERENCE PAPER;
DRUG DEVELOPMENT;
EXPERIMENTAL THERAPY;
HUMAN;
MEMORY DISORDER;
MENTAL DISEASE;
NERVE REGENERATION;
NEUROLOGIC DISEASE;
NEUROPROTECTION;
NONHUMAN;
STEM CELL TRANSPLANTATION;
UNITED STATES;
ALZHEIMER DISEASE;
ANIMALS;
COGNITION DISORDERS;
DRUG DISCOVERY;
GABA-A RECEPTOR AGONISTS;
GLUCURONIDASE;
HUMANS;
MEMORY DISORDERS;
MOLECULAR TARGETED THERAPY;
NERVE REGENERATION;
NERVE TISSUE PROTEINS;
NEUROPROTECTIVE AGENTS;
PHOSPHODIESTERASE 5 INHIBITORS;
STEM CELL TRANSPLANTATION;
|
|
EID: 79952749578
PISSN: 13697056
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (2)
|
|
References (0)
|
